EMLY Trademark

Medical services; medical diagnostic services; medical analysis services related to the treatment of patients; analysis of medical data for the diagnosis and treatment of persons; medical services, namely, immunotherapy services; medical care, namely, personalized medical services; provision of medical information; provision of medical information regarding t-cells, identification of pathogens, immune response and the treatment of disease; information, advisory and consultancy services relating to the aforesaid

Scientific laboratory services; computer system analysis in relation to computerised data; analysis of medical data for scientific and medical research and development purposes; scientific laboratory services, namely, t-cell repertoire decoding services for scientific and medical research and development purposes; scientific laboratory services, namely, sequencing of cells for scientific and medical research and development services; Platform as a Service (PaaS) featuring computer software platforms for scientific and medical research and development, t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Platform as a Service (PaaS) featuring computer software platforms for t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Software as a Service (SaaS) services featuring software for scientific and medical research and development services, t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Software as a Service (SaaS) services featuring software for t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Software as a Service (SaaS) services featuring software for predicting, determining and analysing t-cell specificity; Software as a Service (SaaS) services featuring software for describing the profiles of t-cell receptors and t-cell receptor sequences; scientific research, namely, single cell immune profiling and analysis services; scientific research, namely, t-cell specificity analysis services; pharmaceutical research and development services; medical research services, namely, prediction of immune response, identification of pathogens for medical purposes, t-cell repertoire decoding services for medical purposes, and sequencing of cells for medical purposes; information, advisory and consultancy services relating to the aforesaid